Dimenhydrinate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00985 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | allergic urticaria | KG + DL |
| 2 | cold urticaria | KG + DL |
| 3 | nasal cavity disease | KG + DL |
| 4 | common cold | KG + DL |
| 5 | pharyngitis | KG + DL |
| 6 | acute laryngopharyngitis | KG + DL |
| 7 | urticaria (disease) | KG + DL |
| 8 | recalcitrant atopic dermatitis | KG + DL |
| 9 | angioedema | KG + DL |
| 10 | IgE responsiveness, atopic | KG + DL |
| 11 | myopia 26, X-linked, female-limited | KG + DL |
| 12 | myopia X-linked | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.